Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral Treated People With Human Immunodeficiency Virus (HIV)

RESPOND Study Group , Frédérique Chammartin, Amanda Mocroft, Alexander Egle (Co-author), Robert Zangerle, Colette Smith, Cristina Mussini, Ferdinand Wit, Jörg Janne Vehreschild, Antonella d'Arminio Monforte, Antonella Castagna, Laurent Bailly, Johannes Bogner, Stéphane de Wit, Raimonda Matulionyte, Matthew Law, Veronica Svedhem, Joan Tallada, Harmony P Garges, Andrea MarongiuÁlvaro H Borges, Nadine Jaschinski, Bastian Neesgaard, Lene Ryom, Heiner C Bucher

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

University Hospital Basel and University of Basel
Austrian HIV Cohort Study (AHIVCOS)
University College London
Modena HIV Cohort
AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort
University Hospital of Cologne
Italian Cohort Naive Antiretrovirals (ICONA)
IRCCS San Raffaele Scientific Institute
Université Côte d'Azur-Centre Hospitalier Universitaire de Nice
CHU Saint-Pierre
University of New South Wales
Karolinska Institute and Karolinska University Hospital
European AIDS Treatment Group (EATG)
ViiV Healthcare

Research output: Contribution to journal › Original Article › peer-review

Sort by
Weight
Alphabetically

Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral Treated People With Human Immunodeficiency Virus (HIV)

Fingerprint

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology